Manufacturer: Deus Medical, Europe
Pharmaceutical name: Growth Hormone-Releasing Peptide
Pack: 1 vial (2 mg)
```html
HEXARELIN (Growth Hormone-Releasing Peptide) is a synthetic agonist of the ghrelin/growth hormone secretagogue receptor. It is utilized in treating children with growth hormone deficiency, adults with GH deficiency, catabolic states, and obesity. It is available as a HEXARELIN (Growth Hormone-Releasing Peptide) 2mg/vial injection, which includes 2mg of Growth Hormone-Releasing Peptide along with excipients.
HEXARELIN Mechanism of Action:
HEXARELIN is a synthetic version of the ghrelin receptor. Ghrelin is recognized for its role in enhancing hunger and appetite. Additionally, it promotes the release of growth hormone by interacting with the ghrelin/growth hormone secretagogue receptor (GHS-R). HEXARELIN similarly influences GHS-R. The precise mechanism for growth hormone release following GHSR stimulation remains uncertain. Nonetheless, research indicates that it directly impacts the pituitary gland and hypothalamus, as well as GHRH and somatostatin.
HEXARELIN Dosage:
As prescribed by the healthcare provider.
HEXARELIN Side Effects:
Redness, itching, increased appetite, fatigue, and excessive sweating.
HEXARELIN Interactions:
Insulin, testosterone, ethinylestradiol, growth hormone, IGF-1.
```